OPNT - Opiant Pharmaceuticals EPS beats by $2.10 beats on revenue November, 12 2019 04:14 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (NASDAQ:OPNT): Q3 GAAP EPS of $1.97 beats by $2.10.Revenue of $20.64M (+372.3% Y/Y) beats by $15.12M.Press ReleaseMore news on: Opiant Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,